首页 > 市场调查报告书 > 製药

消化器

胃肠道药物市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按药物类别、应用、给药途径、配销通路和地理位置

市场调查报告书

商品编码

1558400

胃肠道药物市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按药物类别、应用、给药途径、配销通路和地理位置

Gastrointestinal Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Application, Route Of Administration, Distribution Channel, and Geography

出版日期: 2024年08月30日 | 出版商:

The Insight Partners | 英文 211 Pages | 订单完成后即时交付

价格

简介目录图表

根据我们关于「2031 年胃肠道药物市场预测 - 全球分析 - 按药物类别、应用、给药途径和配销通路」的新研究，该市场预计将从 2023 年的 59,713.68 百万美元增长，预计到2031年达1063.0481亿美元；预计 2023-2031 年复合年增长率为 7.3%。胃肠道药物市场的成长归因于胃肠道疾病盛行率的增加以及胃肠道疾病生物製剂的不断发展。

胃肠道药物是一种专门用于治疗影响消化系统（包括食道、胃、肠和相关器官）的疾病和病症的药物。这些药物可以帮助控制症状、减轻疼痛和治疗潜在疾病。

2023年，北美占据全球胃肠道药物市场的主要份额。由于生活方式的改变，胃肠道疾病的发病率不断增加，政府对胃肠道疾病预防和治疗的支持，发达的医疗基础设施，不断发展的製药业，报销范围和行业巨头是推动北方市场增长的一些突出因素美国。

在北美，美国是最大的胃肠道药物市场。在美国，胃肠道疾病的盛行率不断上升，直接增加了对胃肠道药物的需求。克隆氏症和溃疡性结肠炎是两种最常见的发炎性肠道疾病 (IBD)。根据美国克罗恩病和结肠炎基金会 (CCFA) 的报告“关于 IBD 的事实”，美国每年诊断出约 70,000 例新的 IBD 病例。从 2011 年到 2020 年，IBD 的总体盛行率显着增加。此外，与胃肠道疾病相关的研究和开发资金的增加预计将增加对开发新型治疗药物的关注。根据 2022 年发表的一项题为「子宫内膜异位症被低估」的研究，克罗恩病研究获得了 9000 万美元的资助，即每位患者 130.07 美元。

美国食品药物管理局（FDA）的批准可能会支持市场的成长。例如，2020年5月，美国FDA核准Qinlock（ripretinib）锭剂作为晚期胃肠道间质瘤（GIST）的四线治疗。 2024 年 5 月，Strides Pharma 的仿製药硫糖铝口服混悬剂 1gm/10mL 获得美国 FDA 批准，用于治疗胃肠道疾病以及胃溃疡、胃食道逆流 (GERD) 和胃部发炎并预防应激性溃疡。

因此，该市场的成长是由胃肠道疾病的日益普及、市场参与者的发展以及美国主要市场参与者的存在所推动的。

胃肠道药物的策略性措施为未来提供市场机会

在胃肠道药物市场中营运的公司不断关注产品批准、合作、融资、协议和新产品发布等策略发展，这有助于他们提高销售额、扩大地理覆盖范围并提高迎合更大市场需求的能力。现有客户群。以下提到了胃肠道药物市场主要参与者采取的一些策略性倡议

2023 年 9 月，Vivante Health 在新投资者 Mercato Partners 领投的 B 轮融资中完成了 3,100 万美元的融资，以推进数位消化健康平台的发展。新的资金主要是由于最新的 GIThrive 平台增强功能而获得的，这些增强功能凸显了该平台在正确的时间提供适当护理的独特能力。 B 系列资本提供持续的技术进步，旨在预测胃肠道疾病的发病和进展并提供完整的虚拟护理。

2024 年 5 月，Strides Pharma Global Pte. Ltd 获得美国 FDA 批准销售硫糖铝口服混悬剂仿製药，1 克/10 毫升。该药物用于治疗胃肠道疾病，如胃溃疡、胃食道逆流和胃部炎症，并有助于避免压力性溃疡。

2023年5月，艾伯维的RINVOQ（upadacitinib）获得美国FDA批准，用于治疗对一种或多种TNF阻断剂反应不足或不耐受的轻度至重度活动性克隆氏症成人患者。这是 FDA 第七次批准 RINVOQ 在风湿病学、皮肤病学和胃肠病学领域的应用，目前它适用于溃疡性结肠炎和克隆氏症。

因此，各公司专注于开发治疗消化系统疾病的药物的策略性倡议可能会在未来几年为胃肠道药物市场提供成长机会。

胃肠道药物市场：竞争格局与主要发展

赛诺菲公司、葛兰素史克公司、强生公司、博士健康公司、阿斯特捷利康公司、武田製药有限公司、艾伯维公司、拜耳公司、Celltrion公司和辉瑞公司是胃肠道药物市场上的主要公司。

美国食品药物管理局、国际胃肠道疾病基金会、美国胃肠病学学院以及国际基础和临床药理学联盟（IUPHAR）是准备胃肠道药物市场报告时参考的主要和次要来源。

胃肠道药物市场 - 主要市场动态
市场驱动因素
- 胃肠道疾病病例不断增加
- 生物製品的不断发展
市场限制
- 生物製剂成本高
- 治疗严重溃疡性结肠炎或克隆氏症的生物药物的平均成本
市场机会
- 公司的策略倡议
未来趋势
- 增加新药开发和人工智慧技术的研究投资
驱动因素和限制的影响：

第 6 章：胃肠道药物市场 - 全球市场分析

胃肠道药物市场收入，2021-2031
胃肠道药物市场预测分析

第 7 章：胃肠道药物市场分析 - 按药物类别

生物製剂
止泻药和泻药
酸中和剂
抗发炎药
止吐药和止吐药
其他的

第 8 章：胃肠道药物市场分析 - 按应用

急躁性肠症候群
发炎性溃疡性结肠炎
克罗恩病
胃肠炎
乳糜泻
其他的

第 9 章：胃肠道药物市场分析 - 按给药途径

口服
注射用

第 10 章：胃肠道药物市场分析 - 按配销通路

医院药房
零售药局
网路药局

第 11 章：胃肠道药物市场 - 地理分析

北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿拉伯聯合大公国
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 12 章：产业格局

概述
胃肠道药物市场的成长策略
有机成长策略
- 概述
无机成长策略
- 概述

第 13 章：公司简介

Sanofi SA
GSK Plc
Johnson & Johnson
Bausch Health Companies Inc
AstraZeneca Plc
Takeda Pharmaceutical Co Ltd
AbbVie Inc
Bayer AG
Celltrion Inc
Pfizer Inc

第 14 章：附录

简介目录图表

Product Code: TIPRE00014758

According to our new research study on "Gastrointestinal Drugs Market Forecast to 2031 -Global Analysis - by Drug Class, Application, Route of Administration, and Distribution Channel," the market is anticipated to grow from US$ 59,713.68 million in 2023 and is projected to reach US$ 106,304.81 million by 2031; it is expected to register a CAGR of 7.3% during 2023-2031. The gastrointestinal drugs market growth is attributed to the increasing prevalence gastrointestinal diseases and increasing developments of biologics for gastrointestinal diseases.

Gastrointestinal drugs are medications specifically designed to treat disorders and conditions affecting the digestive system, which includes the esophagus, stomach, intestines and related organs. These drugs can help manage symptoms, alleviate pain, and treat underlying diseases.

North America accounted for a major share of the global gastrointestinal drugs market in 2023. The North America gastrointestinal drugs market is segmented into the US, Canada, and Mexico. Increasing incidence of gastrointestinal diseases due to change in lifestyle, government support for prevention and treatment of gastrointestinal diseases, presence of well-developed healthcare infrastructure, growing pharmaceutical industry, reimbursement coverage and industry giants are some of the prominent factors propelling the market growth in North America.

In North America, the US is the largest market for gastrointestinal drugs. In the US, the increasing prevalence of gastrointestinal diseases contributes directly to the demand for gastrointestinal drugs. Crohn's disease and ulcerative colitis are two of the most common types of inflammatory bowel diseases (IBD). As per the Crohn's & Colitis Foundation of America (CCFA) report, "Facts about IBD," approximately 70,000 new cases of IBD are diagnosed yearly in the US. The overall prevalence of IBD increased significantly from 2011 to 2020. The study estimates that nearly 1 in 100 Americans have IBD, and ~2.4 million Americans have some form of IBD. Additionally, the rising funding for research and development related to gastrointestinal diseases is expected to increase focus on developing novel treatment medications. Per a study titled "Endometriosis Is Undervalued," published in 2022, Crohn's disease research received US$ 90 million in funding, or US$ 130.07 per patient.

The US Food and Drug Administration (FDA) approvals are likely to support the growth of the market. For instance, in May 2020, the US FDA approved Qinlock (ripretinib) tablets as a fourth-line treatment for advanced gastrointestinal stromal tumors (GIST). In May 2024, Strides Pharma received approval for the generic version of Sucralfate Oral Suspension, 1gm/10 mL, from the US FDA for the treatment of gastrointestinal diseases as well as stomach ulcers, gastroesophageal reflux disease (GERD), and stomach inflammation and prevent stress ulcers.

Therefore, the growth of this market is driven by the growing prevalence of gastrointestinal diseases, developments by the market players, and the presence of major market players in the US.

Strategic Initiatives in Gastrointestinal Drugs to Provide Market Opportunities in Future

Companies operating in the gastrointestinal drugs market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and improve their capacities to cater to a greater than existing customer base. A few strategic initiatives taken by key players operating in the gastrointestinal drugs market are mentioned below

In September 2023, Vivante Health closed US$ 31 million in a Series B funding round led by Mercato Partners, a new investor, to advance the digital digestive health platform. The new funding is mainly received due to the latest GIThrive platform enhancements that highlight the platform's unique ability to provide proper care at the right time. Series B Capital provides continued technological advancements designed to predict the onset and progression of gastrointestinal conditions and provide complete virtual care.

In May 2024, Strides Pharma Global Pte. Ltd received approval from the US FDA to market the generic version of Sucralfate Oral Suspension, 1gm/10 mL. The medication is used for the treatment of gastrointestinal diseases such as stomach ulcers, GERD, and stomach inflammation, as well as to help avoid stress ulcers.

In May 2023, AbbVie received US FDA approval for RINVOQ (upadacitinib) to treat adults with mild to severe active Crohn's disease having an inadequate response or intolerance to one or more TNF blockers. It is the seventh FDA approval for RINVOQ across rheumatology, dermatology, and gastroenterology, where it is now indicated in both ulcerative colitis and Crohn's disease.

Therefore, strategic initiatives by various companies focusing on the development of drugs for the treatment of digestive diseases are likely to offer growth opportunities to the gastrointestinal drugs market in the coming years.

Gastrointestinal Drugs Market: Competitive Landscape and Key Developments

Sanofi SA, GSK Plc, Johnson & Johnson, Bausch Health Companies Inc, AstraZeneca Plc, Takeda Pharmaceutical Co Ltd, AbbVie Inc, Bayer AG, Celltrion Inc, and Pfizer Inc are among the key companies operating in the gastrointestinal drugs market.

The US Food and Drug Administration, International Foundation for Gastrointestinal Disorders, and American college of gastroenterology, and The International Union of Basic and Clinical Pharmacology (IUPHAR) are among the primary and secondary sources referred to while preparing the gastrointestinal drugs market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Gastrointestinal Drugs Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Gastrointestinal Drugs Market - Key Market Dynamics

5.1 Gastrointestinal Drugs Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Cases of Gastrointestinal Diseases
- 5.2.2 Increasing Development of Biologics
5.3 Market Restraints
- 5.3.1 High Cost of Biologics
- 5.3.2 Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
- 5.5.1 Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques
5.6 Impact of Drivers and Restraints:

6. Gastrointestinal Drugs Market - Global Market Analysis

6.1 Gastrointestinal Drugs Market Revenue (US$ Million), 2021-2031
6.2 Gastrointestinal Drugs Market Forecast Analysis

7. Gastrointestinal Drugs Market Analysis - by Drug Class

7.1 Biologics
- 7.1.1 Overview
- 7.1.2 Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Antidiarrheal and Laxatives
- 7.2.1 Overview
- 7.2.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Acid Neutralizers
- 7.3.1 Overview
- 7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Anti-inflammatory Drugs
- 7.4.1 Overview
- 7.4.2 Anti-inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Antiemetic and Antinauseants
- 7.5.1 Overview
- 7.5.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)

8. Gastrointestinal Drugs Market Analysis - by Application

8.1 Irritable Bowel Syndrome
- 8.1.1 Overview
- 8.1.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Inflammatory Ulcerative Colitis
- 8.2.1 Overview
- 8.2.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Crohns Disease
- 8.3.1 Overview
- 8.3.2 Crohns Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Gastroenteritis
- 8.4.1 Overview
- 8.4.2 Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Celiac Disease
- 8.5.1 Overview
- 8.5.2 Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)

9. Gastrointestinal Drugs Market Analysis - by Route Of Administration

9.1 Oral
- 9.1.1 Overview
- 9.1.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Parenteral
- 9.2.1 Overview
- 9.2.2 Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)

10. Gastrointestinal Drugs Market Analysis - by Distribution Channel

10.1 Hospital Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Retail Pharmacies
- 10.2.1 Overview
- 10.2.2 Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
- 10.3.1 Overview
- 10.3.2 Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)

11. Gastrointestinal Drugs Market - Geographical Analysis

11.1 North America
- 11.1.1 North America Gastrointestinal Drugs Market Overview
- 11.1.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.1.2.1 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
  - 11.1.2.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
  - 11.1.2.3 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
  - 11.1.2.4 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.1.3 North America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
  - 11.1.3.1 United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.1.1 United States: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.1.3.1.2 United States: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.1.3.1.3 United States: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.1.3.1.4 United States: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.1.3.2 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.2.1 Canada: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.1.3.2.2 Canada: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.1.3.2.3 Canada: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.1.3.2.4 Canada: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.1.3.3 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.1.3.3.1 Mexico: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.1.3.3.2 Mexico: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.1.3.3.3 Mexico: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.1.3.3.4 Mexico: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.2 Europe
- 11.2.1 Europe Gastrointestinal Drugs Market Overview
- 11.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.2.2.1 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
  - 11.2.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
  - 11.2.2.3 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
  - 11.2.2.4 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.2.3 Europe: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
  - 11.2.3.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.1.1 Germany: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.1.2 Germany: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.1.3 Germany: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.1.4 Germany: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.2.3.2 United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.2.1 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.2.2 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.2.3 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.2.4 United Kingdom: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.2.3.3 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.3.1 France: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.3.2 France: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.3.3 France: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.3.4 France: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.2.3.4 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.4.1 Italy: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.4.2 Italy: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.4.3 Italy: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.4.4 Italy: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.2.3.5 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.5.1 Spain: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.5.2 Spain: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.5.3 Spain: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.5.4 Spain: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.2.3.6 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.2.3.6.1 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.2.3.6.2 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.2.3.6.3 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.2.3.6.4 Rest of Europe: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.3 Asia Pacific
- 11.3.1 Asia Pacific Gastrointestinal Drugs Market Overview
- 11.3.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.3.2.1 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
  - 11.3.2.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
  - 11.3.2.3 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
  - 11.3.2.4 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.3.3 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
  - 11.3.3.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.1.1 China: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.1.2 China: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.1.3 China: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.1.4 China: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.3.3.2 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.2.1 Japan: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.2.2 Japan: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.2.3 Japan: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.2.4 Japan: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.3.3.3 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.3.1 India: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.3.2 India: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.3.3 India: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.3.4 India: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.3.3.4 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.4.1 Australia: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.4.2 Australia: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.4.3 Australia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.4.4 Australia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.3.3.5 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.5.1 South Korea: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.5.2 South Korea: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.5.3 South Korea: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.5.4 South Korea: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.3.3.6 Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.3.3.6.1 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.3.3.6.2 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.3.3.6.3 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.3.3.6.4 Rest of APAC: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.4 Middle East & Africa
- 11.4.1 Middle East & Africa Gastrointestinal Drugs Market Overview
- 11.4.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.4.2.1 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
  - 11.4.2.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
  - 11.4.2.3 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
  - 11.4.2.4 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.4.3 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
  - 11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.4.3.1.2 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.4.3.1.3 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.4.3.1.4 Saudi Arabia: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.4.3.2 South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.2.1 South Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.4.3.2.2 South Africa: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.4.3.2.3 South Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.4.3.2.4 South Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.4.3.3 United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.3.1 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.4.3.3.2 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.4.3.3.3 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.4.3.3.4 United Arab Emirates: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.4.3.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.4.3.4.1 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.4.3.4.2 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.4.3.4.3 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.4.3.4.4 Rest of Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
11.5 South & Central America
- 11.5.1 South & Central America Gastrointestinal Drugs Market Overview
- 11.5.2 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  - 11.5.2.1 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Drug Class
  - 11.5.2.2 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Application
  - 11.5.2.3 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
  - 11.5.2.4 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
- 11.5.3 South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast Analysis - by Country
  - 11.5.3.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.1.1 Brazil: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.5.3.1.2 Brazil: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.5.3.1.3 Brazil: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.5.3.1.4 Brazil: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.5.3.2 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.2.1 Argentina: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.5.3.2.2 Argentina: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.5.3.2.3 Argentina: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.5.3.2.4 Argentina: Gastrointestinal Drugs Market Breakdown, by Distribution Channel
  - 11.5.3.3 Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
    - 11.5.3.3.1 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Drug Class
    - 11.5.3.3.2 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Application
    - 11.5.3.3.3 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Route Of Administration
    - 11.5.3.3.4 Rest of South & Central America: Gastrointestinal Drugs Market Breakdown, by Distribution Channel

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in Gastrointestinal Drugs Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Sanofi SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GSK Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnson & Johnson
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bausch Health Companies Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 AstraZeneca Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 AbbVie Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bayer AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Celltrion Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Pfizer Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Gastrointestinal Drugs Market Segmentation
Table 2. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 3. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 4. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 5. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 6. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 7. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 8. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 9. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 10. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 11. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 12. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 13. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 14. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 15. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 16. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 17. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 18. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 19. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 21. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 22. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 23. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 24. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 25. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 26. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 27. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 29. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 30. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 31. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 32. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 33. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 34. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 35. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 36. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 37. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 38. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 39. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 40. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 41. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 42. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 43. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 44. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 45. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 46. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 47. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 48. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 49. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 50. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 51. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 52. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 53. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 54. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 55. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 57. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 58. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 59. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 60. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 61. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 62. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 63. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 64. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 65. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 66. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 67. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 68. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 69. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 70. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 71. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 72. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 73. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 74. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 75. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 76. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 77. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 78. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 79. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 80. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 81. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 82. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 83. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 84. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 85. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 86. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 87. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 88. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 89. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 90. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 91. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 92. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 93. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 94. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 95. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 96. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 97. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 98. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 99. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 100. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 101. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 102. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 103. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 104. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 105. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 106. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
Table 107. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 108. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Route Of Administration
Table 109. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million) - by Distribution Channel
Table 110. Recent Organic Growth Strategies in Gastrointestinal Drugs Market
Table 111. Recent Inorganic Growth Strategies in the Gastrointestinal Drugs Market
Table 112. Glossary of Terms, Gastrointestinal Drugs Market

List Of Figures

Figure 1. Gastrointestinal Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Gastrointestinal Drugs Market Revenue (US$ Million), 2021-2031
Figure 5. Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 6. Gastrointestinal Drugs Market Share (%) - by Drug Class (2023 and 2031)
Figure 7. Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Anti-inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Gastrointestinal Drugs Market Share (%) - by Application (2023 and 2031)
Figure 14. Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Crohns Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gastrointestinal Drugs Market Share (%) - by Route Of Administration (2023 and 2031)
Figure 21. Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Gastrointestinal Drugs Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 24. Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. North America: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 29. United States: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. United Kingdom: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Asia Pacific: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 45. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. Rest of APAC: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. Middle East & Africa: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 50. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 51. South Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. United Arab Emirates: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Rest of Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 54. South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. South & Central America: Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 56. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 57. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of South & Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. Growth Strategies in Gastrointestinal Drugs Market